NEW YORK (AP) - Drugmaker GlaxoSmithKline is opening up its research cupboards and labs to outside scientists in an unusual effort to trigger more research on neglected tropical diseases.
The British company also says its researchers should be able in 2012 to seek approval for the first vaccine against malaria, a mosquito-borne parasitic disease that kills a million people a year.
Glaxo has several drugs in testing to treat malaria as well, but it is offering scientists worldwide free access to extensive data on 13,500 other compounds that appear to work against malaria.
The company is to announce that Wednesday, along with plans to open its research labs in Spain to academic scientists wanting to collaborate in finding medicines for poor countries.
Web Search powered by YAHOO!
|
LifestylesLifestyles
GSK offers scientists labs, data to fight malaria
NEW YORK (AP) - Drugmaker GlaxoSmithKline is opening up its research cupboards and labs to outside scientists in an unusual effort to trigger more research on neglected tropical diseases.
By:
|
WNCT
Published: January 20, 2010
Published: January 20, 2010
Email
Facebook
Google
Twitter
Favorites
MoreAdvertisement
View More:
Health_Medical_Pharma,
Malaria,
Mosquito-Borne Parasitic Disease,
Neglected Tropical Diseases,
New York,
Spain,
Technology_Internet
Not what you're looking for? Try our quick search:
Reader Comments
*Facebook Account Required to Comment. If you are not already logged into Facebook, please click the comment button to do so.Deal of the Day
Advertisement
Interactive Radar
Advertisement
Featured Blogger
Reel Reviews
Updated: 02/10/2012
Nine On Your Side's Phillip Sayblack shares his take on the latest movie and dvd releases.
More Posts by Reel Reviews
Hot Topics on WNCT.com
Advertisement
Advertisement